Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Mitek Systems CEO Max Carnecchia discusses the forward outlook and company strategy on TheWatchList with Nicole Petallides.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Scott Carter. Executive Chairman and Interim CEO.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
South Africa's History: From Boer Wars to Present Geopolitics|Thula Simpson,Professor,University of Pretoria
00:10:00
David Archer Highlights Savannah Resources' Mina do Barroso Lithium Project in Portugal.
00:10:00
Exploration Updates from Galen McNamara on Hughes and Mogion Projects
00:10:00
Sugar Capital invests in the brands and technology that power the future of trade|Will Hawthorne,General Partner,Sugar Capital
00:10:00
Navigating Market Trends: Weekly Insights by KAsset | Kasikorn Asset Management
00:10:00
Fed Chair Powell Urges Patience Amid Economic Uncertainty, Highlights Risks from Tariffs and Public Sentiment on Inflation|Jerome Powell,Chair,Federal Reserve
00:10:00
Jonas Wiström Discusses Ratos' Q4 and 2021 Annual Results | Jonas Wiström, CEO, Ratos.
00:10:00
GFM Services Bhd debuted on the main market of Bursa Malaysia today, recording an 8 sen per share premium.
00:10:00
"High Yield Bond Market Outlook for the Second Half of 2024: Key Insights from AXA’s Fund Manager and BBLAM's Navarat Jeamkijrung"
00:10:00
JLL Announces Acquisition of HFF: Strengthening Capital Markets Leadership and Global Footprint | Christian Ulbrich, CEO, JLL Partners.
00:10:00
Unlocking Mongolia's High-Grade Gold Deposits: A Path to Development
00:10:00
Celebrating 23 Years of Excellence and Sustainability